[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR880001688A - 피리미딘과 푸린염기의 n-포스포닐메톡시 알킬유도체와 그의 제조 방법 - Google Patents

피리미딘과 푸린염기의 n-포스포닐메톡시 알킬유도체와 그의 제조 방법 Download PDF

Info

Publication number
KR880001688A
KR880001688A KR1019870007844A KR870007844A KR880001688A KR 880001688 A KR880001688 A KR 880001688A KR 1019870007844 A KR1019870007844 A KR 1019870007844A KR 870007844 A KR870007844 A KR 870007844A KR 880001688 A KR880001688 A KR 880001688A
Authority
KR
South Korea
Prior art keywords
pyrimidine
purine base
following general
general formula
residue
Prior art date
Application number
KR1019870007844A
Other languages
English (en)
Other versions
KR950004179B1 (en
Inventor
드 클렉 에릭
홀리 앤토닌
로젠버그 이반
Original Assignee
원본미기재
스티칭 레가 브이젯트더블유
쎄스코슬로벤스카 아카데미 브이이디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 스티칭 레가 브이젯트더블유, 쎄스코슬로벤스카 아카데미 브이이디 filed Critical 원본미기재
Publication of KR880001688A publication Critical patent/KR880001688A/ko
Application granted granted Critical
Publication of KR950004179B1 publication Critical patent/KR950004179B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

피리미딘과 푸린염기의 N-포스포닐메톡시 알킬유도체와 그의 제조 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 다음 일반식(I)로 표시되는 피리미딘과 푸린염기의 N-포스포닐메톡시알킬유도체.
    (윗식에서, R은 수소원자 또느 하이드록시메틸기이며, B는 피리미딘 또는 푸린염기의 잔기 (비치환 아데닌잔기는 제외), 알칼리금속, 암모니아 또는 아민염이다.)
  2. 다음 일반식(II)로 표시되는 화합물과 R-톨루엔설포닐메탄포스핀산의 디에스테르를 먼저 반응시키고, 이어서 트리메틸할로게노실란과 반응시키거나 또는,
    B-CH2CH2OH..............................(II)
    (윗식에서, B는 피리미딘 또는 푸린 염기의 잔기이다.)
    피리미딘이나 푸린염기의 알카리금속염과 다음 일반식(III)으로 표시되는 2-브로모에톡시메탄포스핀산의 디에스테르를 반응시켜서
    BrCH2CH2OCH2P(O)(OC2H5)2...................(III)
    다음 일반식(IV)로 표시된느 중간체화합물을 생성시킨 다음,
    B-CH2CH2OCH2P(O)(OC2H5)2..........................(IV)
    (윗식에서, B는 피리미딘 또는 푸린염기의 잔기이다.)
    이를 트리메틸할로게노실란으로 처리시켜서 되어짐을 특징으로 하는 다음 일반식(I)로 표시되는 피리미딘과 푸린염기의 N-포스포닐메톡시알킬유도체의 제조 방법.
    (윗식에서, R은 수소원자이고, B는 피리미딘 또는 푸린염기의 잔기이다.)
  3. 다음 일반식(V)로 표시되는 화합물과,
    B-CH2CH(OH)CH2OH..................................(V)
    (윗식에서, B는 피리미딘 또는 푸린염기의 잔기이다.)
    다음 일반식(VI)로 표시되는 크로로메탄 포스포닐 디클로라이드와 반응시켜서 얻어진 에스테르화합물을,
    CICH2P(O)Cl2.............................(VI)
    다음 일반식(VII)로 표시되는 에스테르화합물로
    이성질체화시킨 다음에 이들을 수용성알카리 금속수산화물로 처리시켜서 되어짐을 특징으로 하는 다음식(I)로 표시되는 피리미딘과 푸린염기의 N-포스포닐메톡시 알킬유도체의 제조 방법.
    (윗식에서, R은 히드록시메틸기이고, B는 피리미딘 또는 푸린염기의 잔기이다.)
  4. 항바이러스활성을 가지며 다음 일반식(I)로 표시되는 화합물을 함유하고 있는 것을 특징으로 하는 치료학적 조성물
    (윗식에서, R은 수소원자 또는 히드록시메틸기이고, B는 활성성분인 피리미딘 또는 푸린염기의 유기잔기이거나 알카리금속, 암모니아 또는 아민염이다)
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR87007844A 1986-07-18 1987-07-18 N-phosphonylmethoxyalkye derivatives of pyrimidine and purine bases and a therapeutical composition therefrom with antiviral activity KR950004179B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZPV5469-86 1986-07-18
CS865469A CS264222B1 (en) 1986-07-18 1986-07-18 N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them

Publications (2)

Publication Number Publication Date
KR880001688A true KR880001688A (ko) 1988-04-26
KR950004179B1 KR950004179B1 (en) 1995-04-27

Family

ID=5399635

Family Applications (1)

Application Number Title Priority Date Filing Date
KR87007844A KR950004179B1 (en) 1986-07-18 1987-07-18 N-phosphonylmethoxyalkye derivatives of pyrimidine and purine bases and a therapeutical composition therefrom with antiviral activity

Country Status (21)

Country Link
US (3) US5142051A (ko)
EP (1) EP0253412B1 (ko)
JP (1) JPH0822866B2 (ko)
KR (1) KR950004179B1 (ko)
AT (1) ATE57932T1 (ko)
AU (1) AU600002B2 (ko)
CA (1) CA1340856C (ko)
CS (1) CS264222B1 (ko)
DE (2) DE19775085I2 (ko)
DK (1) DK170646B1 (ko)
EG (1) EG18273A (ko)
ES (1) ES2036194T3 (ko)
FI (1) FI86856C (ko)
GR (1) GR3002534T3 (ko)
IE (1) IE60117B1 (ko)
IL (1) IL83235A (ko)
LU (1) LU90155I2 (ko)
NL (1) NL970036I2 (ko)
NZ (1) NZ221100A (ko)
PT (1) PT85354B (ko)
ZA (1) ZA875283B (ko)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
AU613592B2 (en) * 1986-11-18 1991-08-08 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral phosophonomethoxy-alkyene purine and pyrimide derivatives
US5650510A (en) * 1986-11-18 1997-07-22 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
JPH0217199A (ja) * 1988-07-05 1990-01-22 Japan Tobacco Inc ２’−デオキシ−β−アデノシンの製造方法
US5688778A (en) * 1989-05-15 1997-11-18 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Nucleoside analogs
US5302585A (en) * 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
EP0452935B1 (en) * 1990-04-20 1995-06-21 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
CZ285420B6 (cs) * 1990-04-24 1999-08-11 Ústav Organické Chemie A Biochemie Avčr N-(3-Fluor-2-fosfonylmethoxypropyl)deriváty purinových a pyrimidinových heterocyklických bazí, způsoby jejich přípravy a použití
CS276072B6 (en) * 1990-08-06 1992-03-18 Ustav Organicke Chemie A Bioch (2R)-2-/DI(2-PROPYL)PHOSPHONYLMETHOXY/-3-p-TOLUENESULFONYLOXY -1- TRIMETHYLACETOXYPROPANE AND PROCESS FOR PREPARING THEREOF
DE69132276T2 (de) * 1990-08-10 2001-03-01 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic, Prag/Praha Verfahren zur herstellung von nukleotiden
DE10399025I2 (de) * 1990-09-14 2007-11-08 Acad Of Science Czech Republic Wirkstoffvorläufer von Phosphonaten
US5208221A (en) * 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
ATE151432T1 (de) * 1991-10-11 1997-04-15 Acad Of Science Czech Republic Antivirale acyclische phosphonomethoxyalkyl substituierte, alkenyl und alkynyl purin und pyrimidin-derivate
US6057305A (en) 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
US5817647A (en) * 1993-04-01 1998-10-06 Merrell Pharmaceuticals Inc. Unsaturated acetylene phosphonate derivatives of purines
US5514798A (en) * 1993-06-02 1996-05-07 Gilead Sciences, Inc. Method and cyclic carbonates for nucleotide analogues
US5656745A (en) * 1993-09-17 1997-08-12 Gilead Sciences, Inc. Nucleotide analogs
JPH09506333A (ja) * 1993-09-17 1997-06-24 ギリアード サイエンシーズ，インコーポレイテッド 治療化合物の投薬方法
US5798340A (en) * 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
US5502177A (en) * 1993-09-17 1996-03-26 Gilead Sciences, Inc. Pyrimidine derivatives for labeled binding partners
US5468752A (en) * 1994-04-04 1995-11-21 Freeman; William R. Treatment of conditions of abnormally increased intraocular pressure by administration of HPMPC and related phosphonylmethoxyalkylcytosines
EP0754046A1 (en) * 1994-04-04 1997-01-22 FREEMAN, William R. Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
US5717095A (en) * 1995-12-29 1998-02-10 Gilead Sciences, Inc. Nucleotide analogs
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US5922695A (en) 1996-07-26 1999-07-13 Gilead Sciences, Inc. Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
DK1256584T3 (da) * 1997-07-25 2004-12-06 Gilead Sciences Inc Fremgangsmåde til fremstilling af adefovir-dipivoxil
ES2237189T3 (es) * 1998-11-02 2005-07-16 Gilead Sciences, Inc. Terapia de combinacion para tratar virus de la hepatitis b.
US6407077B1 (en) 1998-11-05 2002-06-18 Emory University β-L nucleosides for the treatment of HIV infection
US7205404B1 (en) * 1999-03-05 2007-04-17 Metabasis Therapeutics, Inc. Phosphorus-containing prodrugs
CZ20022353A3 (cs) * 2000-01-07 2003-02-12 Universitaire Instelling Antwerpen Deriváty purinu, způsob jejich přípravy a jejich použití
AUPQ806700A0 (en) * 2000-06-08 2000-07-06 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
EA004926B1 (ru) 2000-07-21 2004-10-28 Джилид Сайэнс, Инк. Пролекарственные соединения фосфонатных аналогов нуклеотидов (варианты), способ их получения, способ скрининга для их идентификации и содержащая их композиция, способ антивирусной терапии или профилактики
DK1389207T3 (da) 2001-03-01 2006-04-18 Gilead Sciences Inc Polymorfe og andre krystallinske former af cis-FTC
CN1329404C (zh) * 2001-06-29 2007-08-01 捷克科学院有机化学和生物化学研究所 具有抗病毒活性的6－2'－(膦酰基甲氧基)烷氧基嘧啶衍生物
US7247621B2 (en) * 2002-04-30 2007-07-24 Valeant Research & Development Antiviral phosphonate compounds and methods therefor
US7214668B2 (en) * 2002-05-13 2007-05-08 Metabasis Therapeutics, Inc. Phosphonic acid based prodrugs of PMEA and its analogues
CA2485597C (en) * 2002-05-13 2013-07-02 Metabasis Therapeutics, Inc. Process for preparation of cyclic prodrugs of pmea and pmpa
CN105596356A (zh) * 2003-01-14 2016-05-25 吉里德科学公司 用于联合抗病毒治疗的组合物和方法
SI1644389T1 (sl) 2003-06-16 2011-06-30 Acad Of Science Czech Republic Pirimidinske spojine s fosfonatnimi skupinami kot antivirusni nukleotidni analogi
US20050080053A1 (en) * 2003-08-29 2005-04-14 Biocryst Pharmaceuticals, Inc. Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
WO2005051318A2 (en) * 2003-11-24 2005-06-09 Viropharma Incorporated Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
WO2005090370A1 (en) 2004-02-05 2005-09-29 The Regents Of The University Of California Pharmacologically active agents containing esterified phosphonates and methods for use thereof
US7754718B2 (en) 2004-05-05 2010-07-13 Yale University Antiviral helioxanthin analogs
BRPI0511948A (pt) * 2004-06-08 2008-01-29 Metabasis Therapeutics Inc sìntese de ésteres cìclicos mediada por ácido de lewis
ES2401285T3 (es) * 2004-12-16 2013-04-18 The Regents Of The University Of California Fármacos con el pulmón como diana
WO2006130217A2 (en) * 2005-04-01 2006-12-07 The Regents Of The University Of California Substituted phosphate esters of nucleoside phosphonates
US8642577B2 (en) 2005-04-08 2014-02-04 Chimerix, Inc. Compounds, compositions and methods for the treatment of poxvirus infections
EP2842559A3 (en) 2005-04-08 2015-03-18 Chimerix, Inc. Compounds, compositions and methods for the treatment of viral infections and other medical disorders
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
CN100526315C (zh) 2005-06-16 2009-08-12 浙江医药股份有限公司新昌制药厂 N2-喹啉或异喹啉取代的嘌呤衍生物及其制备方法和其用途
EA019888B1 (ru) 2005-07-25 2014-07-30 Интермьюн, Инк. Промежуточное соединение для получения макроциклических ингибиторов репликации вируса гепатита с и способ его синтеза
AU2006301966A1 (en) * 2005-10-11 2007-04-19 Array Biopharma, Inc. Compounds and methods for inhibiting hepatitis C viral replication
US8076303B2 (en) * 2005-12-13 2011-12-13 Spring Bank Pharmaceuticals, Inc. Nucleotide and oligonucleotide prodrugs
FR2908133B1 (fr) 2006-11-08 2012-12-14 Centre Nat Rech Scient Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
GB0709408D0 (en) * 2007-05-16 2007-06-27 Katholleke Universiteit Leuven Anti-col herpes virus compounds
US20090181931A1 (en) * 2008-01-16 2009-07-16 Oncolys Biopharma, Inc. Antiviral activity of cidofovir against oncolytic viruses
ES2572631T3 (es) 2008-01-25 2016-06-01 Chimerix, Inc. Métodos de tratamiento de infecciones virales
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
US20110059921A1 (en) * 2008-03-27 2011-03-10 Ektar Therapeutics Oligomer-Nitrogenous Base Conjugates
KR20110005869A (ko) * 2008-04-15 2011-01-19 인터뮨, 인크. Ｃ형 간염 바이러스 복제의 신규한 마크로사이클릭 억제제
KR20110075019A (ko) * 2008-10-15 2011-07-05 인터뮨, 인크. 치료용 항바이러스성 펩티드
WO2011011519A1 (en) 2009-07-21 2011-01-27 Chimerix, Inc. Compounds, compositions and methods for treating ocular conditions
JP2013501056A (ja) 2009-08-03 2013-01-10 キメリクス，インコーポレイテッド ウイルス感染およびウイルス誘発腫瘍を治療する組成物および方法
TW201116540A (en) * 2009-10-01 2011-05-16 Intermune Inc Therapeutic antiviral peptides
DK2534150T3 (en) 2010-02-12 2017-06-12 Chimerix Inc METHODS OF TREATING VIRUS INFECTION
EP2371369A1 (en) 2010-04-01 2011-10-05 Institut Gustave Roussy (IGR) EGFR inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer
EP2563367A4 (en) 2010-04-26 2013-12-04 Chimerix Inc METHODS OF TREATING RETROVIRAL INFECTIONS AND ASSOCIATED DOSAGE REGIMES
WO2012079035A1 (en) 2010-12-10 2012-06-14 Sigmapharm Laboratories, Llc Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
CA2825825A1 (en) * 2011-01-27 2012-08-02 The Trustees Of Princeton University Inhibitors of mtor kinase as anti-viral agents
US8999958B2 (en) 2011-04-07 2015-04-07 Johnson Matthey Public Limited Company Forms of cidofovir
DK3578563T3 (da) 2011-12-22 2021-05-31 Geron Corp Guanin-analoger som telomerase-substrater og påvirkere af telomerlængde
EP2846788A1 (en) 2012-05-11 2015-03-18 Akron Molecules AG Use of compounds for the treatment of pain
WO2014068265A1 (en) 2012-10-29 2014-05-08 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
TWI642677B (zh) 2013-03-15 2018-12-01 美國加利福尼亞大學董事會 非環狀核苷膦酸二酯
CN114404427A (zh) 2014-02-13 2022-04-29 配体药物公司 前药化合物及其用途
JP2017520545A (ja) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
SI3194411T1 (sl) 2014-09-15 2022-07-29 The Regents Of The University Of California Nukleotidni analogi
WO2017048956A1 (en) 2015-09-15 2017-03-23 The Regents Of The University Of California Nucleotide analogs
AU2017231824B2 (en) 2016-03-09 2021-07-01 Alios Biopharma, Inc. Acyclic antivirals
EP3737676B1 (en) 2018-01-09 2024-03-06 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU521577B2 (en) * 1977-02-24 1982-04-22 Wellcome Foundation Limited, The 9-hydroxyethoxymethyl guanine phosphates
US4287188A (en) * 1977-02-24 1981-09-01 Burroughs Wellcome Co. Purine derivatives
DE2909709A1 (de) * 1979-03-12 1980-09-25 Kailash Kumar Dr Gauri Verfahren zur herstellung von nucleotidderivaten, neue nucleotidderivate und daraus hergestellte arzneimittel
NO833526L (no) * 1982-09-30 1984-04-02 Syntex Inc Fremgangsmaate for fremstilling av guanidinderivater med anti-virus-virkning
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
PT78769A (en) * 1983-06-24 1984-07-01 Merck & Co Inc Process for preparing (s)-9-(2,3-dihydroxy-1-propoxymethyl)guanine and derivatives thereof useful as antiviral agents
US4670424A (en) * 1983-09-19 1987-06-02 Merck & Co., Inc. Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides
US4590269A (en) * 1984-03-29 1986-05-20 Syntex (U.S.A.) Inc. Process for preparing the cyclic phosphate ester of substituted 9-(1,3-dihydroxy-2-propoxymethyl)purines
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
AU613592B2 (en) * 1986-11-18 1991-08-08 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral phosophonomethoxy-alkyene purine and pyrimide derivatives
CA1330794C (en) * 1987-03-27 1994-07-19 Phillip Frost Anti-viral compounds, dosage forms and methods

Also Published As

Publication number Publication date
FI873165A (fi) 1988-01-19
JPS6345289A (ja) 1988-02-26
CS264222B1 (en) 1989-06-13
FI86856B (fi) 1992-07-15
EP0253412A2 (en) 1988-01-20
FI86856C (fi) 1992-10-26
NZ221100A (en) 1991-09-25
EG18273A (en) 1992-12-30
EP0253412B1 (en) 1990-10-31
IL83235A0 (en) 1987-12-31
IE60117B1 (en) 1994-06-01
ES2036194T3 (es) 1993-05-16
CS546986A1 (en) 1988-08-16
NL970036I1 (nl) 1997-12-01
DE3765864D1 (de) 1990-12-06
US5142051A (en) 1992-08-25
AU7575987A (en) 1988-01-21
DK373487D0 (da) 1987-07-17
US5641763A (en) 1997-06-24
NL970036I2 (nl) 1998-03-02
LU90155I2 (fr) 1997-12-22
PT85354B (pt) 1990-04-30
DK170646B1 (da) 1995-11-20
IE871944L (en) 1988-01-18
ZA875283B (en) 1988-03-30
IL83235A (en) 1992-11-15
US5869467A (en) 1999-02-09
DK373487A (da) 1988-01-19
EP0253412A3 (en) 1989-04-26
CA1340856C (en) 1999-12-21
PT85354A (en) 1987-08-01
JPH0822866B2 (ja) 1996-03-06
FI873165A0 (fi) 1987-07-17
KR950004179B1 (en) 1995-04-27
ATE57932T1 (de) 1990-11-15
DE19775085I2 (de) 2004-01-15
AU600002B2 (en) 1990-08-02
GR3002534T3 (en) 1993-01-25

Similar Documents

Publication Publication Date Title
KR880001688A (ko) 피리미딘과 푸린염기의 n-포스포닐메톡시 알킬유도체와 그의 제조 방법
KR900001711A (ko) 디포스폰산 유도체, 이들을 제조하는 방법 및 이들 화합물을 함유하는 제약조성물
ES2032749T3 (es) Acidos oxoftalazinil-aceticos heterociclicos.
EP0188749A3 (en) Derivatives of fumeric acid, process for their preparation and pharmaceutical compositions containing them
KR960702462A (ko) 콘트라스트제로 유용한 트리사이클로폴리아자매크로사이클로포스폰산, 그의 착체 및 유도체(tricyclopolyazamacrocyclo-phosphonic acids, complexes and derivatives thereof, for use as contrast agents)
DE69509065T2 (de) Asymmetrische hydrierung von beta- oder gamma-ketoestern und von beta- oder gamma-ketoamiden
FR2446838A1 (fr) Derives peptidiques d'acides phosphoniques
GB1090466A (en) Phosphorus-containing derivatives of 1-ª‰-d-arabino-furanosylcytosine
FR2381733A1 (fr) Procede de preparation de m-bromo-a,a,a-trifluorotoluenes
MY110450A (en) Imidazolylmethyl-pyridines, their production their use as pharmaceuticals and pharmaceutical compositions containing them
KR910004563A (ko) 4,4-이중 치환된 피페리딘 유도체들과 그 화합물을 함유하는 약제학적 조성물 및 그것들의 제조 방법
CA2364199A1 (fr) Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES367096A1 (es) Un procedimiento para la preparacion de acido (cis-1,2-epo-xipropil)-fosfonico o un ester o sal del mismo.
US4195026A (en) Substituted furans from butenolides
GB2159158A (en) Cyclic diphosphonites, their preparation and uses
JPS6118749A (ja) ジシクロペンタジエン誘導体に基づく新規金属イオン制御剤
ATE34740T1 (de) (bis(hydroxymethyl)methyl)-isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
KR950700246A (ko) E형 프로스타글라딘류의 제조방법
GB1377329A (en) Disubstituted n- aminomethylene- thiol -thiono- phosphoric acid ester amides process for their production and their use as insecti cides and acaricides
SU875816A1 (ru) Способ получени диметиловых эфиров L-оксиалкилфосфоновых кислот содержащих функциональные группы
US3882201A (en) Thiophosphoric acid triesters
JPS57142926A (en) Preparation of difluoroethene derivative
HUT56111A (en) Process for producing 2-formylbenzylphosponic acid derivatives and antiviral pharmaceutical compositions comprising such compounds
MD113C2 (ro) Procedeu de obţinere a fenilalchilaminelor sau ale sărurilor acestor compuşi
FR2683222B1 (fr) Procede de production d'acides, de sels et/ou esters aminoalcanephosphoniques.

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090423

Year of fee payment: 15

EXPY Expiration of term